SavingsInvestmentsWealth ManagementAbout UsContact Us
BusinessPersonal
Become a client
Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range140.28 | 145.42
52-Wk Range |
Last Close141.23
Mkt Cap (m)372,332.03
Dividend yield2.69%
ISINUS4781601046
Volume11,127,206
Exchange VenueNYS

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Key Information
Price/Earning25.09
Price/Book6.26
Price/Sales4.62
P/CF16.19
Rev Growth (3 year avg)4.51
EPS Growth (3 year avg)-0.02
Operating Margin % 24.47
Net Margin %18.42
Return on Equity25.36
Debt/Equity0.47

Documents

Prospectus
en 09/11/2017
Annual Report
en 29/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)74,33170,07471,89076,45081,58182,059
Operating Income (m)20,95918,06521,13618,71420,04920,080
Net Income (m)16,32315,40916,5401,30015,29715,119
Basic EPS5.805.566.040.485.705.72
Avg. Diluted Shares Outstanding (m)2,8642,8132,7892,7452,7292,684
Balance Sheet
USD201420152016201720182019
Current Assets (m)59,31160,21065,03243,08846,03345,274
Non Current Assets (m)71,80873,20176,176114,215106,921112,454
Total Assets (m)131,119133,411141,208157,303152,954157,728
Current Liabilities (m)25,08527,74726,28730,53731,23035,964
Total Liabilities (m)------
Total Equity (m)69,75271,15070,41860,16059,75259,471
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)18,47119,27918,76721,05622,20123,416
Capital Expenditure (m)-3,714-3,463-3,226-3,279-3,670-3,498
Figures are quoted in USD unless stated otherwise
-
No change
$
141.23
Last Price
Savings
Investments
Wealth Management
News and Updates
About Us
Contact Us
Support
Follow Us
© 2019 MeDirect Bank (Malta) plc. All rights reserved.